Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
06/2014
06/05/2014US20140154268 Alpha5-beta1 antibodies and their uses
06/05/2014US20140154267 Use of interleukin-4 antagonists and compositions thereof
06/05/2014US20140154266 Methods of treating a metabolic syndrome by modulating heat shock protein (hsp) 90-beta
06/05/2014US20140154261 Pharmaceutical composition for treatment and/or prophylaxis of cancer
06/05/2014US20140154260 B-7 related nucleic acids and polypeptides useful for immunomodulation
06/05/2014US20140154259 Method for the treatment of inflammatory disorders
06/05/2014US20140154258 Pharmaceutical compositions containing antibodies to neuropeptide head activator and methods thereof
06/05/2014US20140154256 Anti-il1alpha/beta dual variable domain immunoglobulin and uses thereof
06/05/2014US20140154255 Anti-vegf antibodies and their uses
06/05/2014US20140154254 Heterodimeric immunoglobulins
06/05/2014US20140154253 Bispecific Asymmetric Heterodimers Comprising Anti-CD3 Constructs
06/05/2014US20140154252 Single-chain multivalent binding proteins with effector function
06/05/2014US20140154251 Anti c-met antibody and uses thereof
06/05/2014US20140154250 Single-chain multivalent binding proteins with effector function
06/05/2014US20140154249 Novel chemokine binding polypeptides capable of inhibiting the course of autoimmunity, inflammation and cancer
06/05/2014US20140154248 Recombinant immunotoxin targeting mesothelin
06/05/2014US20140154245 Humanized anti-emap ii antibody and use thereof
06/05/2014US20140154243 Specific binding agents to hepatocyte growth factor
06/05/2014US20140154242 Immunoglobulin variants and uses thereof
06/05/2014US20140154241 Binding peptides i
06/05/2014US20140154239 Anti-interferon alpha monoclonal antibodies and methods for use
06/05/2014US20140154238 Compositions And Methods For Treating, Diagnosing And Monitoring Disease
06/04/2014EP2738259A2 ADAM6 mice
06/04/2014EP2738258A2 ADAM6 mice
06/04/2014EP2738252A1 Antibody for detecting epithelial ovarian cancer marker and method for diagnosing epithelial ovarian cancer
06/04/2014EP2738250A1 Antibody for detecting epithelial ovarian cancer marker and method for diagnosing epithelial ovarian cancer
06/04/2014EP2738180A1 Binding proteins comprising at least two binding domains against HER2.
06/04/2014EP2738179A1 Antibody purification
06/04/2014EP2738178A1 Antibody purification
06/04/2014EP2737907A2 Anti-icos antibodies and their use in treatment of oncology, transplantation and autoimmune disease
06/04/2014EP2736928A1 Sur-binding proteins against erbb3
06/04/2014EP2736927A1 Novel anti-cxcr4 antibody and its use for the detection and diagnosis of cancer
06/04/2014EP2736926A1 Use of the antibody i-3859 for the detection and diagnosis of cancer
06/04/2014EP2736925A2 Anti-vegf single variable domains fused to fc domains
06/04/2014EP2736534A1 Combination therapy for the treatment of cd19+ b-cell malignancies symptoms comprising an anti-cd19 maytansinoid immunoconjugate and rituximab
06/04/2014EP2736532A2 Compositions and methods for improving potency and breadth or hiv antibodies
06/04/2014EP2736529A2 Stabilized formulations containing anti-pcsk9 antibodies
06/04/2014CN1867667B Coronavirus, nucleic acid, protein and methods for the generation of vaccine, medicaments and diagnostics
06/04/2014CN103842823A Molecular marker for early indentification of pleural mesothelioma patients, and expression analysis method for same
06/04/2014CN103842504A Antibody for detecting epithelial ovarian cancer marker and method for diagnosing epithelial ovarian cancer
06/04/2014CN103842503A Antibody for detecting epithelial ovarian cancer marker and method for diagnosing epithelial ovarian cancer
06/04/2014CN103842383A Multi-specific fab fusion proteins and methods of use
06/04/2014CN103842382A Antibody polypeptides that antagonize CD40
06/04/2014CN103842381A An antibody inducing antigen-specific t cell tolerance and use thereof
06/04/2014CN103842380A Anti-VEGF single variable domains fused to Fc domains
06/04/2014CN103842379A Methods and reagents for creating monoclonal antibodies
06/04/2014CN103842030A Methods of treating cancer using pd-1 axis binding antagonists and mek inhibitors
06/04/2014CN103841993A Human enterovirus specific antibodies and their uses in diagnostics
06/04/2014CN103841992A Methods of treating or preventing cholesterol related disorders
06/04/2014CN103834667A Chemosynthetic extracellular region gene fragment of streptococcus pneumonia PspA protein, and expression and application thereof
06/04/2014CN103834619A Duck virus hepatitis virus, duck virus hepatitis inactivated vaccine and preparation method of duck virus hepatitis inactivated vaccine
06/04/2014CN103834617A Human enterovirus 71-type C4-subtype lethal strain SD095 and its application
06/04/2014CN103833855A Readily isolated bispecific antibodies with native immunoglobulin format
06/04/2014CN103833854A Immunoglobulin variants and uses thereof
06/04/2014CN103833853A Novel death receptor agonistic polyvalent antibody, and application thereof in preparing anti-tumor drug
06/04/2014CN103833852A Bispecific antibody aiming at phosphatidylinositols protein polysaccharide-3 and T cell antigen
06/04/2014CN103833851A Single-domain antibody aiming at apolipoprotein A1 and application thereof
06/04/2014CN103833850A Preparation method and application of LC3-I antibody
06/04/2014CN103833849A Preparation method and application of ESAT6-CFP10 (Early Secreted Antigen Target 6-Culture Filtrate Protein 10) antibody
06/04/2014CN103833848A Egg yolk antibody for preventing and curing muscovy duck parvovirus diseases
06/04/2014CN103833847A Porcine circovirus-resistant refined egg yolk antibody and preparation method thereof
06/04/2014CN103833839A C-type lectin as well as preparation method and application thereof
06/04/2014CN103833830A Conservative neutralizing epitope polypeptide of Coxsackievirus A16 and application thereof
06/04/2014CN102898517B Anti-West Nile virus non-structural protein 1 antibodies and application thereof
06/04/2014CN102830225B Hemagglutinin and immunizing antigen from naturally avirulent strain of avian influenza virus
06/04/2014CN102766213B Monoclonal antibody, enzyme-linked immunosorbent assay method and kit for detecting furaltadone residue marker AMOZ
06/04/2014CN102766212B Monoclonal antibody, enzyme-linked immunosorbent assay method and kit for detecting residues of fluoroquinolones
06/04/2014CN102766211B Monoclonal antibody, enzyme-linked immunosorbent assay method and kit for detecting arsanilic acid, nitarsone and Carbarsone
06/04/2014CN102649816B Application of high mobility group box (HMGB) protein and antibody to preparation of ostrea rivularis anti-infection immune preparation
06/04/2014CN102649815B Application of AIF1 (Allograft Inflammatory Factor 1) protein and antibody to preparing southern oyster anti-infectious immune preparation
06/04/2014CN102617493B Mequindox artificial antigens and antibodies prepared by same
06/04/2014CN102558348B Single-chain antibody for resisting influenza viruses, preparation method for single-chain antibody, application of single-chain antibody
06/04/2014CN102477085B Construction and application of Candida albican growth-related factor Cas5 mutant
06/04/2014CN102464719B Murine anti-clenbuterol monoclonal antibody and its application
06/04/2014CN102448987B Anti-VEGF monoclonal antibody and pharmaceutical composition comprising said antibody
06/04/2014CN102167740B Fully human anti-VEGF (Vascular Endothelial Growth Factor) monoclonal antibody and preparation method as well as application thereof
06/04/2014CN101952454B Anti-IFNAR1 antibodies with reduced Fc ligand affinity
06/04/2014CN101613409B PDGFR-alpha antibody
06/04/2014CA2836032A1 Diagnostic test and treatment for a neurological disorder
06/03/2014US8742082 Compositions and methods for influencing satiety, lipid metabolism, and fat utilization
06/03/2014US8742076 Nemorubicin metabolite and analog reagents, antibody-drug conjugates and methods
06/03/2014US8742075 Monoclonal antibodies against ANGPTL3
06/03/2014US8742074 Optimized FC variants
06/03/2014US8741876 Therapeutic agent for ulcerative colitis
06/03/2014US8741850 Compounds modulators of VEGF activity and uses thereof
06/03/2014US8741847 Agent and methods for reducing inflammatory markers
06/03/2014US8741832 Pegylated albumin and uses thereof
06/03/2014US8741810 In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells
06/03/2014US8741615 Magnetic nanoparticle with biocompatibility
06/03/2014US8741588 Monoclonal antibodies against PBP2A derived from MRSA and methods of use
06/03/2014US8741586 Antibodies against HER2 truncated variant CTF-611
06/03/2014US8741576 Heteroclitic analogs and related methods
06/03/2014US8741300 Immunoconjugates with an intracellularly-cleavable linkage
06/03/2014US8741298 APOE immunotherapy
06/03/2014US8741297 Preparation of isolated agonist anti-EDAR monoclonal antibodies
06/03/2014US8741296 Adenocarcinoma specific antibody SAM-6, and uses thereof
06/03/2014US8741295 PD-1 antibodies and PD-L1 antibodies and uses thereof
06/03/2014US8741294 Anti-CεmX antibodies capable of binding to human mIgE on B lymphocytes
06/03/2014US8741293 Naturally occurring autoantibodies against alpha-synuclein that inhibit the aggregation and cytotoxicity of alpha-synuclein
06/03/2014US8741292 Proteins and methods for modulating cell activity
1 ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 ... 1494